Status
Conditions
Treatments
About
The aim of the current study is to evaluate the Impact of Hyperbaric Oxygen Therapy on Vocal Performance in Professional Singers
Full description
Professional singers frequently face occupational risks that affect the health and function of their vocal folds. Vocal fold pathologies such as vocal folds edema, nodules, polyps, laryngitis, and muscle tension dysphonia are common among singers and can lead to significant alterations in voice quality and performance endurance. Traditional therapeutic approaches often include voice rest, vocal training, and in some cases, pharmacological interventions or surgery. However, these methods can be either only partially effective, require extended downtime, which is impractical for professional singers, or expose the singer to potentially significant side effects as in the case of the commonly used steroids interventions.
Hyperbaric oxygen therapy (HBOT) has emerged as a potential innovative treatment for enhancing tissue healing and managing various medical conditions. Research has demonstrated HBOT's efficacy in enhancing tissue repair and modulating inflammatory responses, making it a compelling candidate for treating vocal fold injuries. Despite its potential, the application of HBOT in improving vocal fold function has not been thoroughly investigated. This study aims to fill this gap by evaluating the effectiveness of HBOT in enhancing vocal performance, through a prospective, randomized, controlled design. This research will provide robust evidence of the potential benefits of HBOT, offering an alternative or adjunct therapy that could improve the management of vocal health in the singing profession.
In the following text, we will review the physiology of the vocal folds, the common pathophysiology in professional singers, and the physiological effect of the new protocols of HBOT.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
70 participants in 1 patient group
Loading...
Central trial contact
Shai Efrati, Prof
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal